Liposomal Vincristine: The Central Role of Drug Retention in Defining Therapeutically Optimized Anticancer Formulations-Reference-Cited by-同舟云学术

Liposomal Vincristine: The Central Role of Drug Retention in Defining Therapeutically Optimized Anticancer Formulations

Published:1998 Issue: Volume: Page:29-49
ISSN:
Container-title:Long Circulating Liposomes: Old Drugs, New Therapeutics
language:
Short-container-title:

Author:

Boman Nancy L.,Cullis Pieter R.,Mayer Lawrence D.,Bally Marcel B.,Webb Murray S.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-662-22115-0_3

Reference33 articles.

1. Carter SK, Livingston RB. Plant products in cancer chemotherapy. Cancer Treat Rep 1976; 60a141–1156.

2. Sieber SM, Mead JAR, Adamson RH. Pharmacology of antitumor agents from higher plants. Cancer Treat Rep 1976; 60: 1127–1139.

3. Owellen RJ, Owens AH Jr, Donigian DW. The binding of vincristine, vinblastine, and colchicine to tubulin. Biochem Biophys Res Commun 1972; 47: 685–691.

4. Owelien RJ, Hartke CA, Dickerson RM, Hains, FO. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class. Cancer Res 1976; 36: 1499–1502.

5. Jackson DV Jr, Bender RA. Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro. Cancer Res 1979; 39:4346-4349.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomal Doxorubicin: the Sphingomyelin/Cholesterol System Significantly Enhances the Antitumor Efficacy of Doxorubicin;AAPS PharmSciTech;2023-02-09

2. Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine;International Journal of Molecular Sciences;2022-11-02

3. Passive and semi-active targeting of bone marrow and leukemia cells using anionic low cholesterol liposomes;Journal of Drug Targeting;2016-05-16

4. Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine;Cancer Chemotherapy and Pharmacology;2012-12-05

5. Influence of Drug-to-Lipid Ratio on Drug Release Properties and Liposome Integrity in Liposomal Doxorubicin Formulations;Journal of Liposome Research;2008-01